Cite
MLA Citation
Andrés J M Ferreri et al.. “Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.” Lancet, vol. 3, no. 5, 2016, pp. e217–e227. http://access.bl.uk/ark:/81055/vdc_100054496086.0x000007